Search
for
Sort by
Research 30 of 45
- Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- Heterozygous Variants of the SLC39A4 Gene and Possible Increased Risk for Developing Acrodermatitis Enteropathica with Kaposi’s Varicelliform Eruption
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Role of skin enzymes in metabolism of topical drugs
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- A prospective, interventional, randomized, open-label, comparative, three-arm, parallel allocation, single-center clinical study to evaluate the effectiveness of Venusia CeraPlus cream and lotion as an adjuvant in the treatment of atopic dermatitis
- Advances in dermatology research: A comprehensive literature review
- The Itchy Scalp
- Lichen Planopilaris
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Hair follicle immune privilege and its collapse in alopecia areata
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Common Skin Disorders in Pediatric Skin of Color
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation